Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

about

Interventions for bronchiectasis: an overview of Cochrane systematic reviews The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?

P2860

Q24186645-72AD556E-3CCE-4D9E-9741-255D9F2D3846 Q40093203-81444059-041E-4859-85B7-E4C7FDEB441A Q48031392-C5D58A59-9E07-46CD-B66B-DB377F0EC36F

P2860

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

Item

http://www.wikidata.org/entity/Q44780772

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@en

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@nl

type

Item

label

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@en

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@nl

prefLabel

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@en

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@nl

P1476

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

@en

P2093

A Barbato

http://www.w3.org/2001/XMLSchema#string

D Snijders

http://www.w3.org/2001/XMLSchema#string

F Lunardi

http://www.w3.org/2001/XMLSchema#string

I Bertozzi

http://www.w3.org/2001/XMLSchema#string

I Kozuh

http://www.w3.org/2001/XMLSchema#string

S Calgaro

http://www.w3.org/2001/XMLSchema#string

S Quartesan

http://www.w3.org/2001/XMLSchema#string

P2860

The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.

Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants.

Effective mucus clearance is essential for respiratory health.

Mucolytics in cystic fibrosis.

Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.

Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis.

Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries.

Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.

Long-term use of nebulized human recombinant DNase1 in two siblings with primary ciliary dyskinesia.

P304

529-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/039463201302600228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23755770

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

about

P2860

P2860

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921